1. Home
  2. CPIX vs NXPL Comparison

CPIX vs NXPL Comparison

Compare CPIX & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$4.29

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.63

Market Cap

25.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
NXPL
Founded
1999
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
25.6M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
NXPL
Price
$4.29
$0.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
203.0K
143.4K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,278,349.00
$57,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.21
N/A
52 Week Low
$1.85
$0.43
52 Week High
$7.25
$2.30

Technical Indicators

Market Signals
Indicator
CPIX
NXPL
Relative Strength Index (RSI) 82.95 42.37
Support Level $2.42 $0.59
Resistance Level $4.56 $0.70
Average True Range (ATR) 0.38 0.06
MACD 0.27 0.00
Stochastic Oscillator 91.58 14.23

Price Performance

Historical Comparison
CPIX
NXPL

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: